Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Myopia and Presbyopia Treatment Market Growth From $24.56 Billion In 2026 To $33.56 Billion By 2030 At A CAGR Of 8.1%
The market for myopia and presbyopia treatments has experienced robust expansion throughout recent years, projecting a substantial increase from $22.63 billion in 2025 to $24.56 billion in 2026, reflecting a compound annual growth rate of 8.6%. This historical growth trajectory has been significantly influenced by a burgeoning elderly demographic, the widespread use of vision-correcting eyewear, an escalation in myopia cases linked to prolonged screen usage, early advancements in refractive surgical procedures, and a comparatively low level of consciousness regarding proactive eye health management.
The market dedicated to treating myopia and presbyopia is poised for substantial expansion over the coming years, projecting a rise to $33.57 billion by 2030 with a compound annual growth rate (CAGR) of 8.1%. This anticipated expansion during the forecast period is driven by several key factors, including a burgeoning demand for sophisticated surgical interventions, greater acceptance of presbyopia-correcting lenses, an upward trend in the utilization of pharmaceutical treatments, advancements in diagnostic technologies for eye care, and a broader reach of preventive screening initiatives. Furthermore, significant trends expected to shape this market include a heightened adoption of multifocal and cutting-edge contact lenses, an increasing preference for laser and refractive surgical procedures, a growing inclination towards orthokeratology (ortho-k) for myopia management, enhanced use of prescription eye drops targeting presbyopia, and an expanded scope of early vision screening and proactive healthcare programs.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7892&type=smp
Myopia and Presbyopia Treatment Market Development Factors: Which Trends Are Supporting Demand?
The increasing prevalence of conditions affecting sight is anticipated to fuel the expansion of the market focused on treating myopia and presbyopia. Vision impairment, characterized by a substantial decrease in an individual’s capacity to see and process visual data, consequently impedes their ability to perceive and comprehend their environment. This heightened occurrence of vision impairment can invigorate advancements in myopia and presbyopia treatments, fostering greater public awareness, technological innovation, increased capital infusion, enhanced accessibility to interventions, and ultimately, superior results for individuals seeking remedies for their visual challenges. To illustrate, in August of 2023, the World Health Organization, a UN body headquartered in Switzerland, reported that approximately 2.2 billion individuals worldwide experience impairment of their near or distance vision, with a concerning 1 billion cases being either preventable or lacking any form of treatment. Refractive errors and cataracts stand out as the primary contributors to visual loss globally, yet a mere 36% of those affected by distance impairment due to refractive errors and only 17% of individuals impacted by cataracts have obtained suitable medical attention. Consequently, the escalating rate of vision impairment serves as a significant impetus for the growth trajectory of the myopia and presbyopia treatment sector.
Myopia and Presbyopia Treatment Market Segment Landscape And Growth Potential
The myopia and presbyopia treatment market covered in this report is segmented –
1) By Type: Myopia, Presbyopia
2) By Age Group: Children And Young Adults, Adults, Geriatrics
3) By End-Use: Hospitals, Eye Care Clinics Or Ophthalmic Centers
Subsegments:
1) By Myopia: Pharmacological Treatments, Orthokeratology Lenses, Refractive Surgery, Spectacles And Contact Lenses
2) By Presbyopia: Multifocal Lenses, Monovision Contact Lenses, Corneal Inlays, Presbyopia-Correcting Surgery
Myopia and Presbyopia Treatment Market Transformation Trends: Which Innovations Are Driving Change?
Leading entities within the myopia and presbyopia treatment sector are actively introducing novel products, including specialized sunglass lenses engineered to counteract myopia, with the objective of attracting a broader clientele, thereby boosting sales figures and enhancing overall revenue. These myopia-controlling sunglass lenses are crafted to aid in curbing the advancement of nearsightedness, particularly when individuals are exposed to outdoor or brightly lit environments. To illustrate, a significant development occurred in May of 2023 when HOYA, a prominent optical technology firm headquartered in Thailand, unveiled its MiYOSMART sun spectacle lenses, specifically designed to combat myopia in pediatric populations. The unique advantage of MiYOSMART resides in its pioneering method for retarding myopia’s progression in children, coupled with effective shielding against harsh sunlight. This dual functionality is realized through two distinct lens varieties: photochromic lenses known as MiYOSMART Chameleon and polarized lenses branded as MiYOSMART Sunbird, both of which integrate the proprietary DIMS Technology (Defocus Incorporated Multiple Segments). Engineered in partnership with the Hong Kong Polytechnic University, DIMS Technology functions by generating simultaneous defocus across the retina during both distant and close visual tasks. This intricate process involves establishing one focal plane directly on the retina via the lens’s single vision zone(s), while concurrently inducing myopic defocus through the strategic placement of +3.50D defocus lenslets, thereby influencing how light is focused.
Myopia and Presbyopia Treatment Market Competitive Landscape: Who Are The Leading Companies?
Major companies operating in the myopia and presbyopia treatment market are ALCON Inc., Bausch & Lomb Incorporated, Carl Zeiss AG, Essilor Ltd., Johnson & Johnson Vision Inc., Nidek Corporation, Topcon Corporation, Zimmer Ophthalmic Systems AG, AbbVie Inc., Orasis Pharmaceuticals Ltd., The Cooper Companies Inc., Staar Surgical Co., Eyenovia Inc., Allergan PLC, Hoya Corporation, Menicon Co. Ltd., CooperVision Inc., Visioneering Technologies Inc., AcuFocus Inc., Ocular Therapeutix Inc., SightGlass Vision Inc., Presbia PLC, LensGen Inc., RxSight Inc., Perfect Lens LLC
Access The Complete Myopia and Presbyopia Treatment Market Report:
Myopia and Presbyopia Treatment Market Regional Analysis And Leading Geography
North Americawas the largest region in the myopia and presbyopia treatment market share in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the myopia and presbyopia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
